Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Sereflo Ciphaler 50 microgram / 250 microgram per dose inhalation powder, predispensed

Active Ingredient:
fluticasone propionate , salmeterol xinafoate
Company:  
Cipla EU Ltd See contact details
ATC code: 
R03AK06
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 03 May 2024
{pdf} View or print the patient leaflet as PDF
Cipla EU Ltd
Company image
Address
Dixcart House, Addlestone Road, Bourne Business Park, Addlestone,, KT15 2LE, UK
WWW
http://www.cipla.com
Telephone
+44 (0)1932 264688
Medical Information Direct Line
0800 0472144
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)207 399 4883
Stock Availability
[email protected]